493 Cat Tumors Reveal Shared Cancer Genes Between Felines and Humans

Domestic cats develop cancer at rates comparable to humans and often suffer from the same tumor types - lymphomas, carcinomas, sarcomas. They share our environments, our homes, and frequently our non-cancer diseases, including diabetes. Yet the genetic landscape of feline cancer has remained poorly mapped compared to human oncology, and opportunities to use cross-species comparisons to advance both veterinary and human medicine have gone largely unrealized.

A comprehensive genomic analysis published in Science aims to change that. Bailey Francis and colleagues sequenced cancer-associated genes in 493 samples from 13 different types of feline cancer, alongside matched healthy control tissue from the same animals. The result is the most detailed picture of the cat oncogenome yet produced - and a comparison to nearly 1,000 known human cancer genes that reveals more overlap than expected.

Shared Drivers, Distinct Patterns

Among the cancer-driving genes the team identified in feline tumors, some are strikingly familiar. TP53, the tumor suppressor gene that is mutated in roughly 50% of all human cancers, showed similarly prevalent alterations in cat tumors. Other well-characterized human oncogenes also appeared in the feline data at comparable frequencies.

Beyond the shared territory, the researchers identified cancer-driving genes that appear to play specific roles in feline tumors, tumor-predisposing genetic variants, and evidence for viral sequences within the cat oncogenome - a category of cancer etiology that may be proportionally more relevant in cats than in humans and that could offer new insights into virus-associated cancers more broadly.

The Case for the Cat as a Cancer Research Model

The "One Medicine" approach - the idea that cross-species comparisons can benefit both human and animal health simultaneously - has gained traction in research over the past two decades. Dogs have been extensively studied as cancer models, partly because of their size and anatomical similarities to humans, and partly because they have well-established veterinary oncology practices. Cats have been less systematically studied despite their biological advantages as a research subject.

Cats share the same indoor environments as their human owners, including exposure to household chemicals, pollutants, and dietary patterns. They also share comorbidities: feline diabetes, for instance, closely resembles human Type 2 diabetes in its physiology. These shared exposures and conditions make cats potentially more informative than animals kept in controlled laboratory environments, where diet and environment are standardized in ways that do not reflect real-world cancer risk factors.

The sample size in this study - 493 tumors across 13 cancer types - provides enough statistical power to identify recurring mutations within specific tumor categories, a prerequisite for identifying patterns that could be clinically actionable.

Paths to Application

The researchers outline several directions their findings could support. In veterinary medicine, the newly identified potentially actionable mutations could guide the development of targeted treatments for cats - a growing field given that cancer is a leading cause of death in domestic cats and owners increasingly seek sophisticated treatment options.

For human oncology, cats with spontaneous cancer could serve as test cases for drugs before human trials, providing evidence about efficacy and toxicity in a large mammal with naturally occurring tumors rather than artificially induced ones. Cats also often develop tumors in body sites - the oral cavity, the skin, the mammary glands - where human cancers have historically been difficult to study in small-animal models.

The viral sequence findings may open a separate line of investigation. If viral sequences contribute to certain categories of feline cancer, understanding the mechanisms could inform research into human cancers with established viral causes, including cervical cancer and some liver cancers.